↪ Click here to view our IAS roadmap

The 13th annual conference of the International AIDS Society (IAS) will be from July 13 – 17 in Kigali, Rwanda. IAS 2025 comes at a defining moment. Scientific advances in prevention, treatment and potential avenues for a cure, are within reach, but global funding cuts are placing these innovations and their scientific discovery at risk. All this is jeopardizing the gains that communities, advocates, and researchers have fought for decades to achieve.

New research on the HIV prevention pipeline is expected to be shared alongside evidence on how the dismantling of foreign aid and the retreat from the US’ commitments to science and global health are impacting lives and livelihoods. Every aspect of the HIV response is under attack—from basic research and clinical development to policy, programs, and global access to life-saving treatment and prevention. 

See AVAC’s new report, which lays out what’s needed at this critical time to get HIV prevention into the hands of those that need it most and join us Monday, July 14 for a satellite session, Re-imagining prevention: Ensuring sustainable PrEP access in an evolving funding context.

More details are below in our IAS 2025 roadmap and sessions of interest guide. 

IAS 2025 Resources

Use AVAC’s Roadmap to find sessions where prevention and the larger issues of global health equity and sustainability are in the spotlight. You can download it as a sortable spreadsheet or PDF. 

Follow events in real time. AVAC will offer comments and updates on Bluesky, and our friends at NAM/AIDSMAP will be reporting throughout the conference. Join the conversation using the conference hashtag #IAS2025.

Satellites, Sessions and Panels featuring AVAC and Partners 

(All times listed are local in Kigali, Rwanda. See the time zone converter here.) 

Sunday, July 13

• Expanding PrEP Access: The Role of HIVST in Uptake and Scale-Up – HIV Self-Testing impact on HIV diagnosis and treatment, Preconference, 09:00 – 10:00, MH2
• Expanding PrEP Access: The Role of HIVST in Uptake and Scale-Up – HIV Self-Testing and PrEP services, Preconference, 10:15 – 11:15, MH2 
• Expanding PrEP Access: The Role of HIVST in Uptake and Scale-Up – Integrating HIV Self-Testing in the Era of Long-Acting PrEP: Innovations and Future Directions, Preconference, 11:45 – 12:45, MH2 
• Building Resilience: Strengthening national leadership, integration, and sustainable HIV programs in an era of funding transition – Sustaining HIV Prevention and Introducing / Scaling Long-Acting Prevention Tools: Navigating a Way Forward in the Current Environment, Preconference, 14:00 – 15:00, MH4 
• Building Resilience: Strengthening national leadership, integration, and sustainable HIV programs in an era of funding transition – Sustaining Key Population Programs amid Declining Donor Support, Preconference, 15:15 – 16:15, MH4 
• Building Resilience: Strengthening national leadership, integration, and sustainable HIV programs in an era of funding transition – Collective Roadmap for Resilient HIV Responses, Preconference, 16:45 – 17:45, MH4

Monday, July 14

• Re-Imagining Prevention: Planning for sustainable PrEP access in the new funding context, Satellite, 09:30 – 11:00, MH1
• Consolidating and Advancing African Leadership of HIV Cure Strategies to Accelerate Cure Research for Africa and the World, Satellite, 11:30 – 12:30, MH2 
• The Future of Person-Centred HIV Prevention: Latest evidence from the African continent, Satellite, 11:30 – 12:30, AD12 
• What’s New in WHO Guidelines: Advancing prevention, testing, and treatment for impact and sustainability, Satellite, 13:00 – 14:30, MH4 
• WHO Session | Towards the Finish Line: Leveraging science to accelerate progress, sustain impact, and shape the future of HIV, Satellite, 15:00 – 16:30, MH4 
• Ending the HIV Epidemic through People, Partnership, Innovation, Sponsor satellite, 15:00 – 16:30, MH1
• 2025: Time to Bring HIV, Sexual and Reproductive Health Together for Better Care, Satellite, 15:00 – 16:30, MH3
• Opening Session, 17:00 – 18:00, Auditorium

Tuesday, July 15

• The Power of Prevention, Sponsor satellite, 07:30 – 08:30, MH4 
• Better Meeting the Needs of People living with HIV, Plenary, 09:00 – 10:30, Auditorium
• From PrEP to Harm Reduction: Scaling up comprehensive HIV prevention strategies, Oral abstract, 10:45 – 11:45, MH3
• How Long-Acting Drugs Can Help End the HIV Pandemic in Africa, Sponsor satellite, 12:15 – 13:15, MH1 
• From Freeze to Forward: Ensuring HIV commodity access and service delivery in a changing funding landscape, Satellite, 12:15 – 13:15, MH3 
• For this Generation and the Next: Lessons learned from early adopters of long-acting PrEP to drive sustainable access, Satellite, 12:15 – 13:15, AD12 
• Confronting the Storm: The future of the HIV response, Special, 13:30 – 14:45, Auditorium 
• No Retreat, No Surrender: Sustaining the HIV response in times of turmoil, Oral abstract, 15:00 – 16:00, MH1 
• Destination Zero New Acquisitions: Hailing a CAB to PrEP success, Oral abstract, 16:30 – 17:30, Auditorium 
• Harnessing the Private Sector to Deliver HIV Prevention, Sponsor satellite, 18:00 – 19:30, MH1 
• Integrating LA PrEP: Lessons learned and conditions for access, Satellite, 18:00 – 19:30, MH2 
• The Future of HIV Prevention Clinical Trials, Satellite, 18:00 – 19:30, MH4 

Wednesday, July 16

• Taking the Holistic View: Syndemics, Plenary, 09:00 – 10:30, Auditorium
• Implementation of Long-Acting PrEP in Real World Settings – the ImPrEP Project, Satellite, 12:15 – 13:15, MH2
• The Double Burden: HIV incidence and prevalence in conflict, Special, 13:45 – 14:45, Auditorium 
• Co-Chair’s Choice, Oral abstract, 15:00 – 16:00, Auditorium
• Let’s Get Real: Implementing PrEP choice in practice, Symposium, 15:00 – 16:00, MH4 
• The Emerging Landscape of PrEP Choice, Oral abstract, 16:30 – 17:30, Auditorium
• Developing Objective Targets for Monitoring PrEP Program Progress, Satellite, 18:00 – 19:30, MH3 

Thursday, July 17

• Getting to Grips with Prevention, Plenary, 09:00 – 10:30, Auditorium
• Purposeful PrEP: New insights on lenacapavir for prevention, Oral abstract, 10:45 – 11:45, MH4
• Nothing About Us Without Us: Strengthening the HIV response through community-led monitoring, Oral abstract, 10:45 – 11:45, MH2
• Big Money and the Big Picture: Funding and HIV epidemiology, Oral abstract, 12:15 – 13:15, Auditorium
• Pregnancy and Long-Acting ARVs for Prevention and Treatment, Symposium, 13:45 – 14:45, Auditorium
• Rapporteur Report-Back Session, Plenary, 15:15 – 16:30, Auditorium
• Closing session, 16:30 – 17:30, Auditorium

The annual International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST) Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.